ArticleBiostatistics (Oxford, England)2025
A Bayesian pharmacokinetics integrated phase I-II design to optimize dose-schedule regimes.
Mengyi Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it